(Q34343274)

1 August 2017

1 reference

title

Microparticles for intranasal immunization (English)

1 reference

1 August 2017

0 references

Vajdy M

1

1 reference

1 August 2017

O'Hagan DT

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1-3

1 reference

1 August 2017

page(s)

127-141

1 reference

Microsphere absorption by the nasal mucosa of the rat

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Properties of homogeneous heat-labile enterotoxin from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

1 reference

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Large porous particles for pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Polymer-grafted starch microparticles for oral and nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Epithelial M cells: gateways for mucosal infection and immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

The Global Alliance for Vaccines and Immunization--a millennial challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Microparticles and polymers for the mucosal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Cationic microparticles: A potent delivery system for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Generation of female genital tract antibody responses by local or central (common) mucosal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900167-3

7 January 2021

10.1016/S0169-409X(01)00167-3

Identifiers

DOI

1 reference

1 August 2017

1 reference